Cite
HARVARD Citation
Chapple, C. (2018). Editorial Comment from Dr Chapple to Long‐term safety and efficacy of the novel β3‐adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study. International journal of urology. p. 677. [Online].